IP Library › Granted Patent US 11,154,709
Granted Patent B2
US 11,154,709 · App. 16/377,458 · Granted Oct 26, 2021

Combination therapy including peripheral nerve field stimulation

Inventors: Ethan A. Rooney (Chapel Hill, NC); Carl D. Wahlstrand (North Oaks, MN); Gary W. King (Fridley, MN); Thomas E. Cross, Jr. (St. Francis, MN); Kenneth T. Heruth (Edina, MN); Paul W. Wacnik (Brookline, MA); Jeffrey S. Evanson (Minneapolis, MN)
Assignee: Medtronic, Inc.
A61N1/36021A61M5/14A61M5/142A61N1/0531A61N1/0534A61N1/0551A61N1/0553A61N1/0558A61N1/36017A61N1/36071A61N1/375A61N1/37211A61M2205/054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,154,709
App. No.
16/377,458
Granted
Oct 26, 2021
Kind
B2
Abstract

Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.

Claims (10)

1. A method comprising:

controlling, via a processor, delivery of a first therapy to a patient via a first implantable element according to a duty cycle such that the first therapy delivery is cycled on and off; and

controlling, via the processor, delivery of a second therapy to the patient via a second implantable element in combination with delivery of the first therapy, wherein the second therapy is not delivered according to a duty cycle, wherein one of the first therapy and the second therapy comprises peripheral nerve field stimulation therapy, and the other of the first therapy and the second therapy comprises a therapy configured to treat pain to the patient in combination with the peripheral nerve field stimulation therapy.

2. The method of claim 1 , further comprising receiving user input requesting delivery of the second therapy, wherein controlling delivery of the second therapy to the patient comprises controlling the delivery of the second therapy to the patient based upon receipt of the request from a user.

3. The method of claim 1 , wherein the first implantable element is configured to deliver the first therapy to a first anatomical region and the second implantable element is configured to deliver the second therapy to a second anatomical region.

4. The method of claim 3 , wherein the first anatomical region comprises one of a spinal cord or a limb of the patient, and wherein the second anatomical region comprises another of the spinal cord or the limb of the patient.

5. The method of claim 1 , wherein the first therapy comprises a first electrical stimulation therapy and the second therapy comprises a second electrical stimulation therapy, and wherein controlling the delivery of the second therapy to the patient in combination with the delivery of the first therapy comprises controlling delivery of the first electrical stimulation therapy to be time-interleaved with the second electrical stimulation therapy.

6. The method of claim 1 , wherein the first therapy comprises a first electrical stimulation therapy and the second therapy comprises a second electrical stimulation therapy, and wherein an amplitude of electrical stimulation pulses of the first electrical stimulation therapy is different from an amplitude of electrical stimulation pulses of the second electrical stimulation.

7. The method of claim 1 , wherein the first therapy comprises a first electrical stimulation therapy and the second therapy comprises a second electrical stimulation therapy, and wherein a frequency of electrical stimulation pulses of the first electrical stimulation therapy is different from a frequency of electrical stimulation pulses of the second electrical stimulation therapy.

8. The method of claim 1 , wherein the first therapy comprises electrical stimulation therapy, and the second therapy comprises drug delivery therapy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2019
From: ROONEY, ETHAN A.; WAHLSTRAND, CARL D.; KING, GARY W.; HERUTH, KENNETH T.; WACNIK, PAUL W.; EVANSON, JEFFREY S.; CROSS, THOMAS E., JR.
To: MEDTRONIC, INC.
Reel/Frame 048820/0410 →
Continuity (11)
Division 15082536 · Mar 28, 2016
Continuation 14696248 · Apr 24, 2015
Continuation 14109049 · Dec 17, 2013
Continuation 11450133 · Jun 9, 2006
Continuation In Part 11374852 · Mar 14, 2006
Continuation In Part 11375492 · Mar 14, 2006
Continuation In Part 11374793 · Mar 14, 2006
Provisional Application 60689203 · Jun 9, 2005
Provisional Application 60700627 · Jul 19, 2005
Provisional Application 60761823 · Jan 25, 2006
Related Publication 20190232058A1 · Aug 1, 2019